Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic

About this trial

Mechanically ventilated intensive care patients will be sampled for a small amount of exhaled breath condensate from the ventilator circuit and for venous blood.

Proteomic analysis of the exhaled breath condensate will be performed using mass spectrometry and in the blood sample, corresponding changes in the DNA, RNA, proteins, and metabolites will be studied. Resulting profiles will be correlated with routinely monitored parameters in order to identify patterns corresponding to various pathologies in order to enable their early detection.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Mechanically ventilated intensive care patients with or without acute hypoxemic respiratory failure

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Proteomic analysis of exhaled breath condensate

    Diagnostic test

    Mechanically ventilated intensive care patients will be sampled for exhaled breath condensate from the ventilator circuit.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Mechanically ventilated patients with primary or secondary lung injury1 intervention
Group B: Mechanically ventilated patients without lung injury1 intervention

Trial outcomes

Primary outcomes

1

Comparison of proteomic patterns of the exhaled breath condensate in mechanically ventilated intensive care patients.

Proteomic patterns of the exhaled breath condensate will be studied in mechanically ventilated intensive care patients. The results will be analysed and compared with the aim to identify patterns specific for the pathological conditions.

Time frame
January 2024 - December 2029

Secondary outcomes

1

Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - DNA

Venous blood sample will be analysed employing targeted analyses of DNA. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate.

Time frame
January 2024 - December 2029
2

Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - RNA

Venous blood sample will be analysed employing targeted analyses of RNA. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate.

Time frame
January 2024 - December 2029
3

Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - proteins

Venous blood sample will be analysed employing targeted analyses of proteins. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate.

Time frame
January 2024 - December 2029
4

Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - metabolites

Venous blood sample will be analysed employing targeted analyses of metabolites. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate.

Time frame
January 2024 - December 2029

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.